SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Flachenecker, P.
Right arrow Articles by Rieckmann, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flachenecker, P.
Right arrow Articles by Rieckmann, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Cytokine mRNA expression in patients with multiple sclerosis and fatigue

Peter Flachenecker

Department of Neurology, Julius-Maximilians University of Würzburg, Josef-Schneider-Strasse 11, D-97080 Würzburg, Germany, peter.flachenecker{at}surfeu.de

Irene Bihler

Department of Neurology, Julius-Maximilians University of Würzburg, Josef-Schneider-Strasse 11, D-97080 Würzburg, Germany

F Weber

Max-Planck-Institute for Psychiatrie, Neurology Section, Munich, Germany

M Gottschalk

Max-Planck-Institute for Psychiatrie, Neurology Section, Munich, Germany

Klaus V Toyka

Department of Neurology, Julius-Maximilians University of Würzburg, Josef-Schneider-Strasse 11, D-97080 Würzburg, Germany

Peter Rieckmann

Department of Neurology, Julius-Maximilians University of Würzburg, Josef-Schneider-Strasse 11, D-97080 Würzburg, Germany

Background: Fatigue is one of the most common disabling symptoms in patients with multiple sclerosis (MS), but the putative role of proinflammatory cytokines remains to be elucidated. Methods: Thirty-seven patients (27 women, 10 men) with relapsing-remitting (n =29) and secondary progressive (n =8) MS, aged 41.0 ± 10.2 years, were studied. Fatigue was assessed by Krupp’s Fatigue Severity Scale (FSS). C ytokine mRNA expression for interferon (IFN)-g, tumor necro sis factor (TNF)-a and interleukin (IL)-10 were measured by real time RT PC R. A utonomic function was evaluated by standard tests for parasympathetic and sympathetic function, as well as by serum levels of norepinephrine and epinephrine. Results: Median levels of TNF-a mRNA expression were significantly higher in MS patients with (FSS]-4.0 and]-5.0, n=26 and n=14, respectively) than in those without fatigue (FSSB-4.0, n =11). No differences were seen for IFN-g and IL-10 mRNA expression. C ytokine levels were not correlated to autonomic tests or to serum catecho lamine levels. Conclusions: These results suggest that TNF-a, as a principal proinflammatory mediator, is associated with MS-related fatigue. This is in support of a patho genic role of the MS-related inflammatory process in the development of fatigue.

Key Words: autonomic dysfunction • cytokines • fatigue • multiple sclerosis • RNA • messenger

Multiple Sclerosis, Vol. 10, No. 2, 165-169 (2004)
DOI: 10.1191/1352458504ms991oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Neurorehabil Neural RepairHome page
D. Kos, E. Kerckhofs, G. Nagels, M.B. D'hooghe, and S. Ilsbroukx
Origin of Fatigue in Multiple Sclerosis: Review of the Literature
Neurorehabil Neural Repair, February 1, 2008; 22(1): 91 - 100.
[Abstract] [PDF]


Home page
Mult SclerHome page
N. Tellez, M. Comabella, E v. Julia, J. Rio, M a. Tintore, L. Brieva, C. Nos, and X. Montalban
Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone
Multiple Sclerosis, August 1, 2006; 12(4): 487 - 494.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G Giovannoni
Multiple sclerosis related fatigue
J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 2 - 3.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C Heesen, L Nawrath, C Reich, N Bauer, K-H Schulz, and S M Gold
Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?
J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 34 - 39.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
C. Heesen, G. Koehler, R. Gross, W. Tessmer, K.-H. Schulz, and S. M Gold
Altered cytokine responses to cognitive stress in multiple sclerosis patients with fatigue
Multiple Sclerosis, February 1, 2005; 11(1): 51 - 57.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. Gottschalk, T. Kumpfel, P. Flachenecker, M. Uhr, C. Trenkwalder, F. Holsboer, and F. Weber
Fatigue and Regulation of the Hypothalamo-Pituitary-Adrenal Axis in Multiple Sclerosis
Arch Neurol, February 1, 2005; 62(2): 277 - 280.
[Abstract] [Full Text] [PDF]



Advertisement